Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States
Keywords: COVID-19, prevalence survey, Mailed data collection, Self-administered at-home testing
AbstractAlthough counts of the novel Coronavirus (SARS-CoV-2) infections and deaths are reported by several sources online, precise estimation of the exposed proportion of the population is not possible in most areas of the world. Estimates of other disease prevalence in the United States are often obtained through in-person seroprevalence surveys. The availability of testing only for individuals with symptoms, combined with stay-at-home and social distancing mandates to stem the spread of the disease, limit in-person data collection options. A probability-based mail survey with at-home, self-administered testing is a feasible method to safely estimate SARS-CoV-2 antibody prevalence within the United States while also easing burden on the U.S. public and health care system. This mail survey could be a one-time, cross-sectional design, or a repeated cross-sectional or longitudinal survey. We discuss several options for designing and conducting this survey.
How to Cite
Frasier, A., Guyer, H., DiGrande, L., Domanico, R., Cooney, D., & Eckman, S. (2020). Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States. Survey Research Methods, 14(2), 131-139. https://doi.org/10.18148/srm/2020.v14i2.7757
Copyright for articles published in this journal is retained by the authors, with first publication rights granted to the journal. By virtue of their appearance in this open access journal, users can use, reuse and build upon the material published in the journal but only for non-commercial purposes and with proper attribution.